Biogen Newsroom

Biogen Analyst Ratings

BenzingaSep 9 11:28 ET

BMO Capital Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $260

Moomoo NewsSep 5 07:31 ET

Optimistic Buy Rating for Biogen on Strategic Cost-Cutting and Growth Asset Prioritization

TipRanksSep 5 07:01 ET

Needham Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $285

Moomoo NewsSep 4 06:31 ET

Biogen Analyst Ratings

BenzingaSep 4 06:26 ET

Biogen's Upward Trajectory: A Buy Rating on Alzheimer's and Pipeline Progress

TipRanksSep 4 06:20 ET

Oppenheimer Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $270

Moomoo NewsSep 3 08:31 ET

Oppenheimer Reaffirms Their Buy Rating on Biogen (BIIB)

TipRanksSep 3 07:50 ET

Needham Maintains Biogen(BIIB.US) With Buy Rating, Maintains Target Price $285

Moomoo NewsAug 19 05:32 ET

Biogen Analyst Ratings

BenzingaAug 19 05:31 ET

Analysts Offer Insights on Healthcare Companies: Enanta Pharmaceuticals (ENTA), Hyperfine (HYPR) and Biogen (BIIB)

TipRanksAug 11 13:03 ET

Mizuho Securities Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $251

Moomoo NewsAug 6 07:40 ET

Biogen Analyst Ratings

BenzingaAug 6 07:26 ET

Mizuho Maintains Outperform on Biogen, Lowers Price Target to $251

BenzingaAug 6 07:26 ET

Mizuho Adjusts Biogen's Price Target to $251 From $277, Keeps Outperform Rating

MT NewswiresAug 5 12:34 ET

Biogen Price Target Cut to $302.00/Share From $340.00 by Truist Securities

Dow JonesAug 5 09:56 ET

Truist Financial Maintains Biogen(BIIB.US) With Buy Rating, Announces Target Price $302

Moomoo NewsAug 5 07:34 ET

Needham Maintains Buy on Biogen, Lowers Price Target to $285

BenzingaAug 5 06:13 ET

Buy Rating Affirmed for Biogen Amid Strong Core Performance and Strategic Growth Initiatives

TipRanksAug 5 02:27 ET

Jefferies Maintains Biogen(BIIB.US) With Buy Rating, Cuts Target Price to $250

Moomoo NewsAug 2 21:32 ET